| P50 | author | Antonio Rosal-Vela | Q59679023 |
| | Lucia Beltran-Camacho | Q90115243 |
| | Borja Antequera-González | Q90115244 |
| | Mª Carmen Durán-Ruiz | Q90115246 |
| P2093 | author name string | Ana Serrano | |
| | Martin Røssel Larsen | |
| | Rafael Moreno-Luna | |
| | Margarita Jimenez-Palomares | |
| | Manuel Rodriguez-Piñero | |
| | Marta Rojas-Torres | |
| | Almudena González-Rovira | |
| | Ismael Sanchez-Gomar | |
| | Jose Angel Alonso-Piñero | |
| | Mª Jesús Extremera-García | |
| | Sara Eslava-Alcon | |
| | Mª Carmen Perez-Segura | |
| P2860 | cites work | Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model | Q24562969 |
| | Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine | Q27027618 |
| | MAP-Kinase Activated Protein Kinase 2 Links Endothelial Activation and Monocyte/macrophage Recruitment in Arteriogenesis | Q27316885 |
| | Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis | Q28205874 |
| | Working hypothesis to redefine endothelial progenitor cells | Q28295515 |
| | Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 |
| | LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling. | Q28508560 |
| | Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies | Q30238970 |
| | Myocyte specific overexpression of myoglobin impairs angiogenesis after hind-limb ischemia | Q30431139 |
| | Myoglobin overexpression inhibits reperfusion in the ischemic mouse hindlimb through impaired angiogenesis but not arteriogenesis | Q30457043 |
| | Murine model of hindlimb ischemia | Q33410763 |
| | Endothelial Progenitors: A Consensus Statement on Nomenclature | Q33722081 |
| | Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease | Q34051561 |
| | Bcl-rambo induces apoptosis via interaction with the adenine nucleotide translocator | Q34295819 |
| | Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis | Q34361910 |
| | Regulation of endothelial cell survival and apoptosis during angiogenesis | Q34688747 |
| | Characterization of a novel mouse model with genetic deletion of CD177 | Q35034567 |
| | The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure. | Q35065245 |
| | Enhancements to angioplasty for peripheral arterial occlusive disease: systematic review, cost-effectiveness assessment and expected value of information analysis | Q35093945 |
| | Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization | Q35111623 |
| | Involvement of endothelial CD44 during in vivo angiogenesis. | Q35221868 |
| | A review of the pathophysiology and potential biomarkers for peripheral artery disease. | Q35723731 |
| | Inflammatory processes in muscle injury and repair | Q36001988 |
| | Endothelial progenitor cells in atherosclerosis | Q36011477 |
| | Leucine Rich α-2 Glycoprotein: A Novel Neutrophil Granule Protein and Modulator of Myelopoiesis | Q36247995 |
| | Androgen Modulates Functions of Endothelial Progenitor Cells through Activated Egr1 Signaling | Q36367037 |
| | Versican: signaling to transcriptional control pathways. | Q36538369 |
| | The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases | Q36762507 |
| | Endothelial progenitor cells derived from Wharton's jelly of the umbilical cord reduces ischemia-induced hind limb injury in diabetic mice by inducing HIF-1α/IL-8 expression | Q36776844 |
| | Lipocalin 2: a potential therapeutic target for breast cancer metastasis | Q59809165 |
| | Pretreatment of Endothelial Progenitor Cells with Osteopontin Enhances Cell Therapy for Peripheral Vascular Disease | Q60341400 |
| | Phosphorylation of Microtubule- Associated Protein 4 Promotes Hypoxic Endothelial Cell Migration and Proliferation | Q64108682 |
| | Hyperbaric oxygen facilitates the effect of endothelial progenitor cell therapy on improving outcome of rat critical limb ischemia | Q64111521 |
| | Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors | Q73075799 |
| | Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome | Q74265891 |
| | Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases | Q81168941 |
| | Autologous G-CSF-mobilized peripheral blood CD34+ cell therapy for diabetic patients with chronic nonhealing ulcer | Q85306616 |
| | Endothelial cell apoptosis in angiogenesis and vessel regression | Q88381327 |
| | Host non-inflammatory neutrophils mediate the engraftment of bioengineered vascular networks | Q88903294 |
| | Endothelial progenitor cells in age-related vascular remodeling | Q89038320 |
| | Endothelial Progenitor Cells: New Targets for Therapeutics for Inflammatory Conditions With High Cardiovascular Risk | Q90455731 |
| | Insights into Endothelial Progenitor Cells: Origin, Classification, Potentials, and Prospects | Q90729475 |
| | Modulating the vascular response to limb ischemia: angiogenic and cell therapies. | Q36908997 |
| | Functions of S100 proteins. | Q37001259 |
| | Vascular repair by endothelial progenitor cells | Q37113091 |
| | Progenitor cell therapy in patients with critical limb ischemia without surgical options | Q37123046 |
| | Therapeutic angiogenesis in critical limb ischemia. | Q37142832 |
| | Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. | Q37173528 |
| | Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence | Q37293820 |
| | The prosurvival protein BAG3: a new participant in vascular homeostasis | Q37465928 |
| | 2016 update of the PRIDE database and its related tools. | Q37507647 |
| | A novel molecule Me6TREN promotes angiogenesis via enhancing endothelial progenitor cell mobilization and recruitment | Q37743869 |
| | Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success | Q38087578 |
| | Therapeutic angiogenesis for critical limb ischemia | Q38392203 |
| | Concise Review: Functional Definition of Endothelial Progenitor Cells: A Molecular Perspective | Q38887411 |
| | Lipocalin-2 enhances angiogenesis in rat brain endothelial cells via reactive oxygen species and iron-dependent mechanisms | Q38923476 |
| | The multitasking neutrophils and their involvement in angiogenesis. | Q38984174 |
| | Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia. | Q39918726 |
| | Nitric oxide regulates neutrophil migration through microparticle formation | Q40035554 |
| | Desmoplakin is required for microvascular tube formation in culture | Q40547005 |
| | Neutrophils, host defense, and inflammation: a double-edged sword | Q40652717 |
| | The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31). | Q42152390 |
| | Highly sensitive and specific Alu-based quantification of human cells among rodent cells | Q42378966 |
| | Alterations in endothelial cell proliferation and apoptosis contribute to vascular remodeling following hind-limb ischemia in rabbits | Q44196185 |
| | Role of CD44 and hyaluronan in neutrophil recruitment. | Q45178626 |
| | Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases | Q45816370 |
| | A subset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice | Q45888478 |
| | Stem cell-based peripheral vascular regeneration | Q47800013 |
| | Regulation of endothelial hemoglobin alpha expression by Kruppel-like factors | Q47928025 |
| | Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies. | Q48144378 |
| | S100 Proteins As an Important Regulator of Macrophage Inflammation. | Q49497885 |
| | Upregulation of BAG3 with apoptotic and autophagic activities in maggot extract‑promoted rat skin wound healing | Q49500682 |
| | Lipocalin-2 ameliorates granulocyte functionality | Q50023310 |
| | Tissue regeneration using endothelial colony-forming cells: promising cells for vascular repair | Q50068661 |
| | The S100A6 calcium-binding protein regulates endothelial cell-cycle progression and senescence. | Q50551664 |
| | The atheroma plaque secretome stimulates the mobilization of endothelial progenitor cells ex vivo. | Q50880007 |
| | Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. | Q53336156 |
| | Society for Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. Introduction. | Q53602474 |
| | The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals. | Q55011363 |
| | Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. | Q55057070 |
| | The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions. | Q55259593 |
| | Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) | Q56287926 |
| | Expression of Neutrophil Gelatinase–Associated Lipocalin in Atherosclerosis and Myocardial Infarction | Q57607666 |
| | Distinct role of autophagy on angiogenesis: highlights on the effect of autophagy in endothelial lineage and progenitor cells | Q58590553 |
| | Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia | Q58816115 |
| P433 | issue | 1 | |
| P921 | main subject | limb ischemia | Q18553514 |
| P304 | page(s) | 106 | |
| P577 | publication date | 2020-03-06 | |
| P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
| P1476 | title | Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia | |
| P478 | volume | 11 | |